Dr. Gurkamal Chatta and his colleagues are conducting a phase I clinical trial of an immunotherapy for men with metastatic prostate cancer that has progressed in spite of standard treatment. “We are targeting an area of need where there are really no other effective therapies.”
Prostate Cancer
I'm proud to be a member of The Original Gentlemen, a car club based out of Niagara Falls, New York. For the past couple of years, we’ve been invited to Roswell Park for the Cruisin’ for a Cure car show and prostate cancer early detection event.
June is Men’s Health Month, a time when we focus on increasing awareness of preventable health problems to encourage men to take more active roles in preventing disease and detecting and treating problems early.
Most men who are diagnosed with prostate cancer face one of just a few options for their treatment plan: watchful waiting—having their physician monitor the level of their prostate-specific antigen, or PSA, to ensure it doesn’t rise incrementally—or curative therapy, usually surgery.
Many dietary studies have been done showing the connection between nutrition and cancer.
The U.S. Supreme Court's unanimous ruling — that companies may no longer patent human genes — resonated across the cancer community, resulting in promising news for cancer patients and researchers.